共 46 条
[1]
Vorchheimer DA(1999)Platelet glycoprotein IIb/IIIa receptor antagonists in cardiovascular disease Jama 281 1407-1407
[2]
Badimon JJ(2000)Incidence of intracranial hemorrhage complicating treatment with glycoprotein IIb/IIIa receptor inhibitors: A pooled analysis of major clinical trials Am J Med 109 213-217
[3]
Fuster V.(2002)Intracerebral hemorrhages associated with neurointerventional procedures using a combination of antithrombotic agents including abciximab Stroke 33 1916-1919
[4]
Memon MA(2000)Frequency of major hemorrhage in patients treated with unfractionated intravenous heparin for deep venous thrombosis or pulmonary embolism: a study in routine clinical practice Arch Intern Med 160 2369-73
[5]
Blankenship JC(2000)Cost and outcome of mechanical ventilation for life-threatening stroke Stroke 31 2346-53
[6]
Wood GC(2004)Bleeding events with abciximab in acute coronary syndromes without early revascularization: An analysis of GUSTO IV-ACS Am Heart J 147 865-873
[7]
Frey CM(2003)Risk of intracranial haemorrhage with combined fibrinolytic and glycoprotein IIb/IIIa inhibitor therapy in acute myocardial infarction Dichotomous response as a function of age in the GUSTO V trial. Eur Heart J 24 1807-14
[8]
Menapace FJ.(2004)Comparison of frequency of hemorrhagic stroke in patients <75 years versus > or =75 years of age among patients receiving glycoprotein IIb/IIIa inhibitors during percutaneous coronary interventions Am J Cardiol 93 346-349
[9]
Qureshi AI(2001)Trend of stroke hospitalization, United States, 1988–1997 Stroke 32 2221-2226
[10]
Saad M(undefined)undefined undefined undefined undefined-undefined